FRANKLIN LAKES, N.J., Dec. 15, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the expansion of its respiratory and ...
FRANKLIN LAKES, N.J., Aug. 1, 2023 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced U.S. Food and Drug Administration (FDA) ...
ZARAGOZA, Spain and FRANKLIN LAKES, N.J., Oct. 21, 2020 /PRNewswire/ -- CerTest Biotec, along with BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today ...
Becton, Dickinson and Company BDX, popularly known as BD, recently announced the expansion of its respiratory and sexually transmitted infection (STI) diagnostics portfolio in Europe. This follows the ...
Assay for Research and Clinical Use Now Globally Available for the BD MAX™ System FRANKLIN LAKES, N.J., Jan. 9, 2023 /PRNewswire/ -- BD (Becton, Dickinson and Company (BDX)) (NYSE: BDX), a leading ...
Becton, Dickinson and Co.’s (BD) diagnostic tool that can check for COVID-19, the flu or respiratory syncytial virus (RSV) has been available in certain European countries since last year. Now, it’s ...
BD Diagnostics, a part of global medical technology company BD (Becton, Dickinson and Company), and Biodiversity SpA, a biotechnology company for molecular diagnostics, announced a regional ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results